Use AirTran Holdings Inc. Common S historical price analysis with your portfolios to hedge against foreign markets instabilities as well as to determine Fund diversification method that is right for you.
Roger Nusbaum submits: There was a peculiar exchange on CNBC the other day between Mark Haines and a guest touting Abbott Labs (ABT) as a value stock. Haines asked why anyone would want to buy such a stinker of a stock, noting that it has lagged badly since the March 2009 low. It is essentially flat since then, versus a 43% lift for the Healthcare Sector SPDR (XLV) and an 88% lift for the S&P 500.
The guest was making a value case for the name, simply concluded that he thinks the market will recognize the...